Sign in
8-K

Current Report

Outlook Therapeutics, Inc. Filed Acc 0001104659-20-059556

Agreement ended

  • Item 1.02 Termination of a material definitive agreement

From the SEC's structured data for this filing

Loading tm2018970d1_8k.htm…